Instituto de Fisiología Experimental (CONICET), Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR). Suipacha 570, 2000, Rosario, Argentina.
Instituto de Fisiología Experimental (CONICET), Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR). Suipacha 570, 2000, Rosario, Argentina.
Toxicology. 2020 Aug;441:152527. doi: 10.1016/j.tox.2020.152527. Epub 2020 Jun 15.
Multidrug resistance-associated protein 2 (Mrp2), expressed at the brush border membrane (BBM) of the enterocyte, is an ABC transporter with relevant intestinal barrier function. Its toxicological relevance lies in preventing absorption and tissue accumulation of dietary contaminants, drugs, and potentially harmful endogenous metabolites. Expression and activity of intestinal Mrp2 is downregulated in LPS-induced endotoxemia. In addition, confocal microscopy studies demonstrated internalization of the transporter to endocytic vesicles. Since IL-1β plays an important role as early mediator of LPS-inflammatory responses, we evaluated whether IL-1β mediates LPS-induced impairment of Mrp2 function. Two protocols were used: I) In vivo administration of LPS (5 mg/kg b.wt., i.p., single dose) to rats in simultaneous with administration of anti-IL-1β (25 μg/kg b.wt., i.p., 4 doses), followed by studies of Mrp2 expression, localization and activity, 24 h after LPS administration; II) In vitro incubation of isolated intestinal sacs with IL-1β (10 ng/mL) for 30 min, followed by analysis of Mrp2 activity and localization. We found that in vivo immunoneutralization of IL-1β partially prevented the decrease of Mrp2 protein expression and activity as well as its internalization to intracellular domains induced by LPS. Involvement of IL-1β in the alteration of Mrp2 localization and activity was more directly demonstrated in isolated intestinal sacs, as incubation with IL-1β resulted in detection of Mrp2 in intracellular regions of the enterocyte in simultaneous with alteration of transport activity. In conclusion, IL-1β induces early internalization of intestinal Mrp2, which could partially explain loss of expression at the BBM under conditions of experimental endotoxemia. Concomitant impairment of Mrp2-dependent barrier function may have pathophysiological relevance since IL-1β mediates the effect of many local and systemic inflammatory processes.
多药耐药相关蛋白 2(Mrp2)表达于肠上皮细胞的刷状缘膜(BBM),是一种具有相关肠道屏障功能的 ABC 转运体。其毒理学相关性在于防止膳食污染物、药物和潜在有害内源性代谢物的吸收和组织蓄积。LPS 诱导的内毒素血症会下调肠道 Mrp2 的表达和活性。此外,共聚焦显微镜研究表明该转运体被内化到内吞小泡中。由于 IL-1β 作为 LPS 炎症反应的早期介质发挥重要作用,我们评估了 IL-1β 是否介导 LPS 诱导的 Mrp2 功能障碍。采用了两种方案:I)同时给予 LPS(5mg/kg b.wt.,腹腔注射,单次剂量)和抗 IL-1β(25μg/kg b.wt.,腹腔注射,4 次剂量),然后在 LPS 给药 24 小时后研究 Mrp2 的表达、定位和活性;II)将分离的肠囊与 IL-1β(10ng/mL)孵育 30 分钟,然后分析 Mrp2 活性和定位。结果发现,体内免疫中和 IL-1β 部分阻止了 LPS 诱导的 Mrp2 蛋白表达和活性降低以及其内化到细胞内结构域。IL-1β 参与 Mrp2 定位和活性的改变在分离的肠囊中更为直接,因为孵育 IL-1β 导致 Mrp2 在肠上皮细胞的细胞内区域被检测到,同时转运活性也发生改变。总之,IL-1β 诱导肠道 Mrp2 的早期内化,这可能部分解释了实验性内毒素血症时 BBM 上表达的丢失。Mrp2 依赖性屏障功能的同时受损可能具有病理生理学相关性,因为 IL-1β 介导了许多局部和全身炎症过程的效应。